>
Switch to:

NovoCure Debt-to-EBITDA

: 62.70 As of Mar. 2021
View and export this data going back to 2015. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

NovoCure's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2021 was $0.0 Mil. NovoCure's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2021 was $572.3 Mil. NovoCure's annualized EBITDA for the quarter that ended in Mar. 2021 was $9.1 Mil. NovoCure's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2021 was 62.70.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

NAS:NVCR' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -6.37   Med: -0.23   Max: 13.21
Current: 13.21

-6.37
13.21

During the past 8 years, the highest Debt-to-EBITDA Ratio of NovoCure was 13.21. The lowest was -6.37. And the median was -0.23.

NAS:NVCR's Debt-to-EBITDA is ranked lower than
96% of the 345 Companies
in the Medical Devices & Instruments industry.

( Industry Median: 1.13 vs. NAS:NVCR: 13.21 )

NovoCure Debt-to-EBITDA Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovoCure Annual Data
Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Debt-to-EBITDA Premium Member Only Premium Member Only Premium Member Only -0.88 -3.21 -6.37 12.25 11.23

NovoCure Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Debt-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.25 4.40 0.19 7.62 62.70

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


NovoCure Debt-to-EBITDA Distribution

* The bar in red indicates where NovoCure's Debt-to-EBITDA falls into.



NovoCure Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

NovoCure's Debt-to-EBITDA for the fiscal year that ended in Dec. 2020 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 444.198) / 39.551
=11.23

NovoCure's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 572.292) / 9.128
=62.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2021) EBITDA data.


NovoCure  (NAS:NVCR) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


NovoCure Debt-to-EBITDA Related Terms


NovoCure Debt-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)